LDLR and Hypercholesterolemia: Drug interventions can regulate the alternative splicing of LDLR pre-mRNA and increase normal LDLR transcripts in hypercholesterolemic patients by affecting the expression of histone methylation and acetylation and controlling hypercholesterolemia [34,35,36].